Madhu Mahankali

Madhu Mahankali has a diverse work experience in the field of scientific research. Starting in 2006, Mahankali worked as a Graduate Research Assistant at the Indian Institute of Technology, Madras, where they focused on the formation of calcium-dependent permeabilization pore in neuro 2A cells. They also played a role in standardizing cell culture and biochemical techniques in the lab.

In 2009, Mahankali joined Wright State University as a PhD student. Their research focused on investigating the novel activity of the lipase PhopsholipaseD2 (PLD2) and its switch between two activities. They designed and conducted experimental approaches using enzyme, protein-lipid based assays, and cell-based bioassays.

In 2014, Mahankali became a Postdoctoral Fellow at the California Institute for Biomedical Research (Calibr), where they continued their research on PLD2 signaling. They also served as an Institute Fellow at Calibr from January 2017 to October 2017.

Mahankali then joined Novozymes in 2017 as a Scientist II. They held this role until December 2019 and played a significant role in the company's scientific research.

Currently, Mahankali works as a Principal Scientist at Spirovant Sciences, Inc., starting from January 2020.

Madhu Mahankali began their education in 2006 at the Indian Institute of Technology, Madras, where they pursued a Masters degree in Biotechnology. Madhu attended this institution until 2008. Following their time at IIT Madras, Mahankali enrolled in Wright State University in 2009 to pursue a Doctor of Philosophy (PhD) in Bio medical sciences. Madhu completed their studies at Wright State University in 2014.